Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
about
Improving Outcomes in Gynaecological Cancer: The Benefits of SubspecialisationCentralisation of services for gynaecological cancerNeoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.If the Mountain Does Not Come to Mohammad: The Significance of Guest Operations for Early Stage Ovarian CancerThe influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.The Effect of Gynecologic Oncologist Availability on Ovarian Cancer Mortality.The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy.Isolated subcutaneous implantation of a borderline ovarian tumor: A case report and review of the literatureOutcomes of advanced epithelial ovarian cancer with integration of metronomic chemotherapy: An Indian rural cancer centre experience.Disparities in use of gynecologic oncologists for women with ovarian cancer in the United StatesManagement of complex pelvic masses using a multivariate index assay: a decision analysisUrokinase-type plasminogen activator receptor: a beacon of malignancy?In Pursuit of Optimal Cytoreduction in Ovarian Cancer Patients: The Role of Surgery and Surgeon.Effect of surgeon training, specialization, and experience on outcomes for cancer surgery: a systematic review of the literature.Analysis of contemporary trends in access to high-volume ovarian cancer surgical care.Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan.Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.Preoperative experience for public hospital patients with gynecologic cancer: Do structural barriers widen the gap?The clinical utility of an elevated-risk multivariate index assay score in ovarian cancer patients.Trends and factors associated with radical cytoreductive surgery in the United States: A case for centralized care.Unstaged cancer: Long-term decline in incidence by site and by demographic and socioeconomic characteristics.Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.Influence of surgical volume on outcome for laparoscopic hysterectomy for endometrial cancer.Emerging concerns when evidence-based medicine is translated into real life: the case of neoadjuvant chemotherapy in ovarian cancer.Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study.Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.No association between TP53 Arg72Pro polymorphism and ovarian cancer risk: evidence from 10113 subjects.Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.Gynecologic oncologists involvement on ovarian cancer standard of care receipt and survival.Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancerParticipation in global health delivery: Survey results from the Society of Gynecologic Oncology
P2860
Q24200973-0D2CE24A-04F2-47C4-892E-B0295D598402Q24201268-603ECEBA-222B-4AE0-AD43-0AC42859C76BQ33626973-FB99516D-D616-4DE2-9E0F-87B05D0C392DQ34360602-77103C82-8737-4F07-A6A5-1D96CEF14DB7Q35828154-AEE02C0A-12C5-483F-AA7A-8BB5CA73E76AQ36161973-698400B7-3FE0-45A8-B3BA-69AD15F614D8Q36608535-11296FFC-F872-4500-BA8D-4FCFCC3BA841Q36688059-09672912-DA48-4F5F-B38D-CFF3CE7DC70AQ36784895-B94596B4-5C4A-4A34-BB87-7066B31469A3Q36918902-4C996D0A-418F-4C22-9457-5AE2EE7EE919Q36925424-89DDA09D-65D7-4E57-83FB-D78B774381C3Q36965471-EEEB4128-859D-4361-9267-60F49CE4180DQ36983005-FB5B8E44-88A3-48D6-82D1-D9D6C2D2F26BQ37428269-5BAB0A09-A72C-480C-8DAE-34A0CA75DDC4Q37483583-13B267C0-B8AD-4FA7-90E9-B7D69C71D46CQ37587811-5331C39C-8625-4916-B094-ECE793451495Q37717738-84BD4F0F-24BF-4062-B77B-D55DE5CC4ECDQ38409656-B8AA04FD-5CD2-4889-BBD6-1BD6D259954EQ38759017-C88582CA-0E08-495A-9B1B-D9DD9544B095Q38800078-AB57A414-68C4-4714-854B-67C4CE47B5FEQ38861948-5AB30620-3740-41A2-B44D-1376FD7ABC3BQ40310403-46025A45-991B-4E1F-B758-656FDC41204DQ41682474-84A79900-EC53-49BC-9E35-B0E45027F9FCQ43997503-E7F1DEC4-B7AB-4F0D-9CDE-44C4A5233541Q44646090-B6C5BEF1-93A6-4EFF-AE10-70227F8C7E40Q45074659-5ECFB372-CDE6-43E0-9D6A-7CFDE578DEDFQ47443109-AFE9E006-D955-4975-88DC-90630B27F998Q49216581-5D0637B5-48D4-4B03-99AC-0F4F662DE2EEQ53054061-6C7B9A9E-36D4-43C5-A3C7-97EB371BCCE3Q55137369-75353F44-2EFC-4FFC-9801-A8B55F2106DCQ57210147-75B71A0C-34CF-477C-A3E1-F6565B5041C0Q58798737-4AAE6FF2-9BFC-41C9-B6AF-A3FE52E6B0CA
P2860
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@en
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@nl
type
label
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@en
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@nl
prefLabel
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@en
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@nl
P2093
P1476
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
@en
P2093
Amreen Husain
Cynthia O'Malley
Daniel S Kapp
Gary S Leiserowitz
Jacob Y Shin
John K Chan
Jonathan S Berek
Kathryn Osann
Nelson N Teng
Rosemary D Cress
P304
P356
10.1097/01.AOG.0000265207.27755.28
P407
P577
2007-06-01T00:00:00Z